Leslie A. Geer

426 total citations
10 papers, 345 citations indexed

About

Leslie A. Geer is a scholar working on Pharmacology, Pharmacology and Biochemistry. According to data from OpenAlex, Leslie A. Geer has authored 10 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Pharmacology and 4 papers in Biochemistry. Recurrent topics in Leslie A. Geer's work include Inflammatory mediators and NSAID effects (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Leslie A. Geer is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Leslie A. Geer collaborates with scholars based in United States, Japan and United Kingdom. Leslie A. Geer's co-authors include Rita A. Halpin, Eric Woolf, Catherine Z. Matthews, Kenneth C. Lasseter, Donghui Cui, Kamlesh P. Vyas, Keith Gottesdiener, Nancy Agrawal, Patrick Larson and Deborah Lowry and has published in prestigious journals such as Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and Drug Metabolism and Disposition.

In The Last Decade

Leslie A. Geer

10 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie A. Geer United States 9 142 93 63 55 47 10 345
Gabriela I. Patilea‐Vrana United States 12 155 1.1× 119 1.3× 44 0.7× 13 0.2× 7 0.1× 18 622
Andrew P. Lea Portugal 10 32 0.2× 47 0.5× 164 2.6× 108 2.0× 6 0.1× 11 676
Andrew Walubo South Africa 13 91 0.6× 135 1.5× 134 2.1× 62 1.1× 6 0.1× 29 493
Helen Gu United States 12 110 0.8× 109 1.2× 75 1.2× 13 0.2× 20 0.4× 19 507
A.J. Harker United Kingdom 9 40 0.3× 43 0.5× 112 1.8× 67 1.2× 28 0.6× 11 407
Madhusudana R. Chaluvadi United States 6 72 0.5× 154 1.7× 44 0.7× 10 0.2× 24 0.5× 9 430
Ralph S. Mazenko United States 13 165 1.2× 73 0.8× 74 1.2× 9 0.2× 33 0.7× 16 545
M. Distel Germany 10 420 3.0× 112 1.2× 61 1.0× 47 0.9× 66 1.4× 14 584
Marc Vermeir Belgium 11 72 0.5× 80 0.9× 44 0.7× 25 0.5× 9 0.2× 17 402

Countries citing papers authored by Leslie A. Geer

Since Specialization
Citations

This map shows the geographic impact of Leslie A. Geer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie A. Geer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie A. Geer more than expected).

Fields of papers citing papers by Leslie A. Geer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie A. Geer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie A. Geer. The network helps show where Leslie A. Geer may publish in the future.

Co-authorship network of co-authors of Leslie A. Geer

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie A. Geer. A scholar is included among the top collaborators of Leslie A. Geer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie A. Geer. Leslie A. Geer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Malcolm, Karl, Ronald S. Veazey, Leslie A. Geer, et al.. (2012). Sustained Release of the CCR5 Inhibitors CMPD167 and Maraviroc from Vaginal Rings in Rhesus Macaques. Antimicrobial Agents and Chemotherapy. 56(5). 2251–2258. 53 indexed citations
2.
Lowry, Deborah, Leslie A. Geer, Ronald S. Veazey, et al.. (2011). Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. Journal of Controlled Release. 156(2). 161–169. 43 indexed citations
3.
Malcolm, Karl, Deborah Lowry, Linda K. Green, et al.. (2010). Pre-treatment with Depo-Provera modifies the pharmacokinetics of CMPD167 in rhesus macaques following vaginal ring administration. 4 indexed citations
4.
Agrawal, Nancy, Catherine Z. Matthews, Ralph S. Mazenko, et al.. (2003). Pharmacokinetics of Etoricoxib in Patients with Renal Impairment. The Journal of Clinical Pharmacology. 44(1). 48–58. 32 indexed citations
5.
Rodrigues, A. David, Rita A. Halpin, Leslie A. Geer, et al.. (2003). Absorption, Metabolism, and Excretion of Etoricoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Healthy Male Volunteers. Drug Metabolism and Disposition. 31(2). 224–232. 64 indexed citations
6.
Agrawal, Nancy, Mark J. Rose, Catherine Z. Matthews, et al.. (2003). Pharmacokinetics of Etoricoxib in Patients with Hepatic Impairment. The Journal of Clinical Pharmacology. 43(10). 1136–1148. 19 indexed citations
7.
Slaughter, Donald, Norihiro Takenaga, Ping Lü, et al.. (2003). METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS. Drug Metabolism and Disposition. 31(11). 1398–1408. 22 indexed citations
8.
Halpin, Rita A., Arturo G. Porras, Leslie A. Geer, et al.. (2002). The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects. Drug Metabolism and Disposition. 30(6). 684–693. 38 indexed citations
9.
Baillie, Thomas A., Rita A. Halpin, B.K. Matuszewski, et al.. (2001). Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques.. PubMed. 29(12). 1614–28. 24 indexed citations
10.
Vyas, Kamlesh P., Rita A. Halpin, Leslie A. Geer, et al.. (2000). Disposition and Pharmacokinetics of the Antimigraine Drug, Rizatriptan, in Humans. Drug Metabolism and Disposition. 28(1). 89–95. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriela I. Patilea‐Vrana Breakdown of academic impact, for papers by Andrew P. Lea Breakdown of academic impact, for papers by Andrew Walubo Breakdown of academic impact, for papers by Helen Gu Breakdown of academic impact, for papers by A.J. Harker Breakdown of academic impact, for papers by Madhusudana R. Chaluvadi Breakdown of academic impact, for papers by Ralph S. Mazenko Breakdown of academic impact, for papers by M. Distel Breakdown of academic impact, for papers by Marc Vermeir
Rankless by CCL
2026